Julie L. Gerberding - Insider Trading & Ownership

Entity
Individual
Location
2000 Galloping Hill Road, Kenilworth, NJ
Summary
The estimated net worth of Julie L. Gerberding is at least $5.82M dollars as of June 9, 2023. Julie L. Gerberding is the EVP, Chief Patient Officer of Merck & Co., Inc. and owns shares of Merck & Co., Inc. (MRK) stock worth about $5.82M.
All Insider Reports
All Insider Reports

Ownership of Julie L. Gerberding

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRK Merck & Co., Inc. EVP, Chief Patient Officer $5.82M Feb 24, 2022
AFTR AfterNext HealthTech Acquisition Corp. Director Aug 11, 2021
CERN CERNER Corp Director Jun 7, 2022
HLVX HilleVax, Inc. Director Jun 7, 2023

Insider Transactions Reported by Julie L. Gerberding:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.